Trial Profile
Clinical Outcome Study in Postoperative Pain Management to Demonstrate the Efficacy and Safety of IONSYS (Fentanyl ITS Iontophoretic Transdermal System) in Daily Clinical Practice and to Assess Its Convenience (IPAC)
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 Aug 2017
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 12 Feb 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 05 Feb 2009 Actual patient numbers (13) added as reported by ClinicalTrials.gov.
- 05 Feb 2009 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.